0001562180-20-003453.txt : 20200507 0001562180-20-003453.hdr.sgml : 20200507 20200507163444 ACCESSION NUMBER: 0001562180-20-003453 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200505 FILED AS OF DATE: 20200507 DATE AS OF CHANGE: 20200507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valentine Karen CENTRAL INDEX KEY: 0001437152 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38584 FILM NUMBER: 20857037 MAIL ADDRESS: STREET 1: C/O ANTIGENICS INC. STREET 2: 3 FORBES RD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-05-05 false 0001434418 CONSTELLATION PHARMACEUTICALS INC CNST 0001437152 Valentine Karen C/O CONSTELLATION PHARMACEUTICALS, INC. 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142 false true false false See Remarks Common Stock 2020-05-05 4 M false 4744.00 11.50 A 4744.00 D Common Stock 2020-05-05 4 S false 4744.00 40.0121 D 0.00 D Common Stock 2020-05-06 4 M false 10099.00 11.50 A 10099.00 D Common Stock 2020-05-06 4 M false 2467.00 8.76 A 12566.00 D Common Stock 2020-05-06 4 S false 12566.00 40.10 D 0.00 D Stock Option (Right to Buy) 11.50 2020-05-05 4 M false 4744.00 0.00 D 2028-07-18 Common Stock 4744.00 109241.00 D Stock Option (Right to Buy) 11.50 2020-05-06 4 M false 10099.00 0.00 D 2028-07-18 Common Stock 10099.00 99142.00 D Stock Option (right to buy) 8.76 2020-05-06 4 M false 2467.00 0.00 D 2029-03-06 Common Stock 2467.00 22425.00 D These trades were made pursuant to a Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $40.00 to $40.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $40.00 to $40.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022. This option was granted on March 7, 2019. The shares underlying the option are scheduled to vest in equal quarterly installments through March 7, 2023. /s/ Emma Reeve, as Attorney-in-Fact for Karen Valentine 2020-05-07